As a fibroblast cell line derived from MS patients show increased lipid peroxidation and diminished GPX4 levels [38], we assume that the observed differences in DRF-mediated GPX4 levels do not depend on the different cell types used, fibroblasts and oligodendrocytes. The gene discussed is GPX4; the disease is myeloid sarcoma.